Latest Breaking News On - Castle biosciences - Page 16 : comparemela.com

Castle Biosciences, Inc Presents Data Supporting the Utility of Its Tests in the Clinical Care of Patients with Skin Cancers at the 2024 Winter Clinical Dermatology Conference - Hawaii

Castle Biosciences, Inc. will present new data across its dermatologic portfolio of commercially available and pipeline gene expression profile tests at the 2024 Winter Clinical Dermatology.

United statesCastle biosciences incCastle biosciencesClinical dermatology conferenceWinter clinicalCoral ballroomPath melanomaMypath melanoma

Castle Biosciences Presents Data Supporting the Utility of Its Tests in the Clinical Care of Patients with Skin Cancers at the 2024 Winter Clinical Dermatology Conference - Hawaii®

.

United statesCastle biosciencesRobert cookCastle decisiondxCastle inflammatory skin disease pipeline programInflammatory skin disease pipeline programCastle biosciences incClinical dermatology conferenceWinter clinicalCoral ballroomPath melanomaMypath melanoma

Castle Biosciences Presents Data Supporting the Utility of Its Tests in the Clinical Care of Patients with Skin Cancers at the 2024 Winter Clinical Dermatology Conference

Castle Biosciences Presents Data Supporting the Utility of Its Tests in the Clinical Care of Patients with Skin Cancers at the 2024 Winter Clinical Dermatology Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCamilla zuckeroCastle decisiondxRobert cookCastle biosciencesSecurities exchangeCastle inflammatory skin disease pipeline programInflammatory skin disease pipeline programCastle biosciences incClinical dermatology conferenceWinter clinicalCoral ballroomPath melanomaMypath melanomaSecurities actSecurities exchange act

Castle Biosciences Chief Operating Officer Kristen Oelschlager Selected Among the Top 25 Women Leaders in Biotechnology by The Healthcare Technology Report -January 09, 2024 at 07:04 am EST

Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that its Chief Operating Officer, Kristen Oelschlager, has been named to The.

New yorkUnited statesCastle biosciencesKristen oelschlagerDerek maetzoldToby juvenalHealthcare technology report topCastle biosciences incHealthcare technologyChief operating officerHealthcare technology reportTop workplaceChief commercial officerMypath melanomaNew york city

Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2023 Results

Expect to deliver 2023 total revenue of more than $210 million, at least 53% growth over 2022 Delivered 70,429 total test reports in 2023, an increase of 59% compared to 2022 Year-end 2023 cash,.

Derek maetzoldCastle biosciencesCastle biosciences incUnaudited fourth quarter endedPath melanomaUnaudited year endedCypher barrettCash equivalentsMarketable investmentMypath melanoma